---
title: "Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results | AORT Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293661671.md"
description: "Artivion, Inc. (NYSE: AORT) announced that its second quarter 2026 financial results will be released on Thursday, August 6, 2026, after market close. The company will host a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a Q&A session with CEO Pat Mackin. Replay details and access information are available via phone numbers and the Investors section of Artivion's website."
datetime: "2026-07-23T12:10:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293661671.md)
  - [en](https://longbridge.com/en/news/293661671.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293661671.md)
---

# Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results | AORT Stock News

, /PRNewswire/ -- **Artivion, Inc. (NYSE: AORT),** a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2026 financial results will be released on Thursday, August 6, 2026, after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question-and-answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.

To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13760537.

The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.

**About Artivion, Inc.**

Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:

**Artivion**

**Gilmartin Group LLC**

**Lance A. Berry**

**Brian Johnston**

**Executive Vice President**

**Phone: 332-895-3222**

**Chief Operating Officer &**

**investors@artivion.com**

**Chief Financial Officer**

  

**Phone: 770-419-3355**

  

SOURCE Artivion, Inc.

### Related Stocks

- [AORT.US](https://longbridge.com/en/quote/AORT.US.md)

## Related News & Research

- [Infleqtion to Report Second Quarter 2026 Financial Results on August 12, 2026 | INFQ Stock News](https://longbridge.com/en/news/294112580.md)
- [Baxter Q2 2026 Earnings Preview](https://longbridge.com/en/news/294224876.md)
- [EssilorLuxottica: Publication of the 2026 Interim Financial Report | ESLOY Stock News](https://longbridge.com/en/news/294233056.md)
- [JSL updates financial events calendar for 2026](https://longbridge.com/en/news/294067473.md)
- [Ciena's Q3 2026 Earnings: What to Expect](https://longbridge.com/en/news/293952665.md)